World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
FDA's approach to approving drugs of pharmaceutical companies and weighing the risks and benefits.
07/01/2005
The questions of safety balanced by the need to let patients have access to drugs that would help them. The processes the FDA uses to arrive at proper decisions.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09.24.2010
FDA Says Two Eczema Products To Carry Cancer-Risk Warnings
Wall Street Journal 01.20.2006
Acting FDA Chief Asserts a Need To Review Drug-Approval Process
Wall Street Journal 09.26.2005
FDA Reviews of New Drugs May Signal Tougher Scrutiny
Wall Street Journal 08.23.2005
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07.01.2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07.22.2005
FDA Rethinks Advisory Panel Process
Wall Street Journal 05.10.2006
FDA Signals It's Open To Drug Trials That Shift Midcourse
Wall Street Journal 07.10.2006
Report Blasts FDA's System To Track Drugs
Wall Street Journal 03.03.2007
China Sentences Former Drug Regulator to Death
New York Times 05.29.2007
Medicare Eases Proposed Restrictions on Anemia Drugs Used by Cancer Patients
New York Times 07.31.2007
Diabetes Drug Backed, but With Warnings
New York Times 07.31.2007
Wall Street Journal 07.31.2007
FDA Questions Data On Amgen, J&J Drugs
Wall Street Journal 09.08.2007
Study Missteps Threaten Turnaround at Schering
Wall Street Journal 01.17.2008
Wall Street Journal 02.27.2008
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03.12.2008
FDA Denies Approval For Merck's Cholesterol Drug
Wall Street Journal 04.28.2008
FDA to Hire Additional Scientists To Expand Drug Safety Operations
Wall Street Journal 04.30.2008
Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline
Wall Street Journal 06.30.2008
FDA Rejects Advisers, Won't Expand Use of J&J Drug
Wall Street Journal 08.22.2008
Wall Street Journal 10.20.2008
FDA Panel Is Split on Risks of Some Asthma Drugs
Wall Street Journal 12.11.2008
Diabetes Drugs to Face Tougher Risk Scrutiny
Wall Street Journal 12.17.2008
FDA Outlays for Morale-Boosting Draw Fire From Lawmakers
Wall Street Journal 01.08.2009
A Wolfe in Regulator's Clothing: Drug Industry Critic Joins the FDA
Wall Street Journal 01.09.2009
CDC, FDA Set to Get New Leaders
Wall Street Journal 01.12.2009
FDA Panel May Recommend High Fence Around Lilly Clot Drug
Wall Street Journal 02.01.2009
FDA Approves a Novel Novartis Drug
Wall Street Journal 06.19.2009
F.D.A. Reveals It Fell to a Push by Lawmakers
New York Times 09.25.2009
Doctors' Spat Exposes FDA Loophole
Wall Street Journal 12.23.2009
Wall Street Journal 12.30.2009
Regulator Defends Avastin Decision
Wall Street Journal 01.07.2011
FDA Says Drug Firms Didn't Finish Follow-Ups
Wall Street Journal 02.09.2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us